Navigation Links
Cellulosic Biofuels Leader Qteros Adds Key Positions
Date:10/24/2009

Kevin F. McLaughlin appointed Chief Financial Officer and Ralph M. Lerner named Senior Vice President of Commercial Development

Marlborough, Mass. (Vocus) October 23, 2009 -- Massachusetts-based biofuels company Qteros, whose breakthrough Q Microbe™ technology turns biomass into cellulosic ethanol, has welcomed Kevin F. McLaughlin and Ralph M. Lerner to the Qteros leadership team.

Mr. McLaughlin brings 30 years of financial and operating management experience from the high tech, biotech, and education industries.

Mr. Lerner has over 20 years of industry experience in general management, business development, and strategy development and implementation in the global petrochemical and energy industry, with companies including BP and Amoco. Mr. Lerner brings to the company a global perspective, having spent six years in Asia; an in-depth understanding of global commodities markets, and extensive experience in developing innovative commercial arrangements.

"Kevin and Ralph arrive at Qteros at a critical time, and we're confident that their backgrounds and skills will help guide our company through our next stages of development and growth," said Qteros president and CEO Dr. William Frey. "As key members of our dynamic leadership team, they will help us build Qteros into an exceptional commercial success."

Mr. McLaughlin most recently served as Chief Operating Officer and member of the Board of Directors at Aptius Education, Inc., a company he helped cofound, which is focused on the acquisition of companies in the areas of career education, vocational and technical training and licensing, and certification programs. From 1996 through 2007, Mr. McLaughlin was with PRAECIS Pharmaceuticals, where as the company's first Chief Financial Officer he had responsibility for private financings, partnership financings, and the company's IPO and secondary stock offerings. In 2004, Mr. McLaughlin became COO and then President and CEO and member of the Board of Directors of PRAECIS and was responsible for negotiations resulting in the sale of the company to GlaxoSmithKline. Earlier in his career he spent 16 years in senior financial roles at Prime Computer and Computervision Corporation.

"Qteros is a fast-moving company with a solid foundation and a great deal of promise in a next-generation industry," said Mr. McLaughlin. "It's very exciting to join the company as it prepares for significant growth."

Mr. Lerner was most recently Vice President of Ventures and Business support for BP's chemicals business based in Shanghai, China, where he served on the Board of Directors and represented BP's shareholder interests in a large joint venture located outside of Shanghai. Prior to that role, he was based in the Chicago area, as general manager of a $600 million global chemical business with manufacturing facilities in the U.S., Canada, and Europe. Earlier in his career, he served as Vice President of Ventures and Development for BP Chemicals based in Hong Kong and Venture Development Manager for Amoco Corporation, as well as holding positions in finance and engineering.

"Throughout my career, I've led multi-functional teams that were focused on creating value through developing and implementing new strategies, projects, and commercial arrangements -- in businesses with a commodity focus and a global perspective," Lerner said. "Bringing that experience to Qteros, a cutting-edge energy company with national and international ties, allows me to apply my skills in one of today's most exciting industries."

Qteros is a venture-backed company committed to delivering innovative process technologies for clean transportation fuels that reduce greenhouse gas emissions at a price competitive with gasoline. The Qteros scientists and business team are dedicated to producing liquid fuels to achieve a sustainable solution to the world's growing energy needs.

See www.qteros.com for more information. Contact: Patricia Charles, 301-887-1060 x111

# # #

Read the full story at http://www.prweb.com/releases/Qteros/Q_Microbe/prweb3098254.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
2. POET to Outline Cellulosic Ethanol's Present, Future at Brazil's Ethanol Summit 2009
3. Solazyme Testing BlueFire Ethanol Cellulosic Sugars in Its Microalgae Renewable Oil Production Process
4. Research Reinforces Economic, Environmental Benefits of Corn Cobs as Source for Cellulosic Ethanol
5. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
6. Verenium Announces First Commercial Cellulosic Ethanol Project
7. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
8. Dartmouth researchers advance cellulosic ethanol production
9. POET Announces That Cellulosic Ethanol Pilot Facility Will Be Operational This Year
10. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
11. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cellulosic Biofuels Leader Qteros Adds Key Positions 
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:3/24/2017)... Controller General of Immigration from Maldives Mr. Mohamed Anwar and ... international IAIR Award for the most innovative high security ePassport and eGates  ... ... Maldives Immigration Controller General, Mr. Mohamed Anwar ... right) have received the IAIR award for the "Most innovative high security ...
(Date:3/23/2017)... 23, 2017 The report "Gesture Recognition and Touchless Sensing ... Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected ... 29.63% between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology ... object recognition technologies, today announced the release of ... (SDK), which provides improved facial recognition using up ... on a single computer. The new version uses ... improve accuracy, and it utilizes a Graphing Processing ...
Breaking Biology News(10 mins):